|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiong Y, Huang BY and Yin JY:
Pharmacogenomics of platinum-based chemotherapy in non-small cell
lung cancer: Focusing on DNA repair systems. Med Oncol. 34:482017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tièche CC, Peng RW, Dorn P, Froment L,
Schmid RA and Marti TM: Prolonged pemetrexed pretreatment augments
persistence of cisplatin-induced DNA damage and eliminates
resistant lung cancer stem-like cells associated with EMT. BMC
Cancer. 16:1252016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhan Y, Zang H, Feng J, Lu J, Chen L and
Fan S: Long non-coding RNAs associated with non-small cell lung
cancer. Oncotarget. 8:69174–69184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pan JJ, Xie XJ, Li X and Chen W: Long
non-coding RNAs and drug resistance. Asian Pac J Cancer Prev.
16:8067–8073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang H, Guan Z, He K, Qian J, Cao J and
Teng L: LncRNA UCA1 in anti-cancer drug resistance. Oncotarget.
8:64638–64650. 2017.PubMed/NCBI
|
|
9
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7:902014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X,
Zhang W, Deng H, Zhou M, Peng S, et al: AFAP1-AS1, a long noncoding
RNA upregulated in lung cancer and promotes invasion and
metastasis. Tumour Biol. 37:729–737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo JQ, Li SJ and Guo GX: Long noncoding
RNA AFAP1-AS1 promotes cell proliferation and apoptosis of gastric
cancer cells via PTEN/p-AKT pathway. Dig Dis Sci. 62:2004–2010.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu W, Bhagat TD, Yang X, Song JH, Cheng Y,
Agarwal R, Abraham JM, Ibrahim S, Bartenstein M, Hussain Z, et al:
Hypomethylation of noncoding DNA regions and overexpression of the
long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and
esophageal adenocarcinoma. Gastroenterology. 144:956–966.e4. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geng J, Li X, Zhou Z, Wu CL, Dai M and Bai
X: EZH2 promotes tumor progression via regulating VEGF-A/AKT
signaling in non-small cell lung cancer. Cancer Lett. 359:275–287.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roche J: The epithelial-to-mesenchymal
transition in cancer. Cancers (Basel). 10(pii): E522018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z, et al: Long non-coding RNA XIST
promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitra R, Chen X, Greenawalt EJ, Maulik U,
Jiang W, Zhao Z and Eischen CM: Decoding critical long non-coding
RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat
Commun. 8:16042017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rigoutsos I, Lee SK, Nam SY, Anfossi S,
Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG,
Rossi S, et al: N-BLR, a primate-specific non-coding transcript
leads to colorectal cancer invasion and migration. Genome Biol.
18:982017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du J, Wang L, Li C, Yang H, Li Y, Hu H, Li
H and Zhang Z: MicroRNA-221 targets PTEN to reduce the sensitivity
of cervical cancer cells to gefitinib through the PI3K/Akt
signaling pathway. Tumour Biol. 37:3939–3947. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramírez-Moya J, Wert-Lamas L and
Santisteban P: MicroRNA- 146b promotes PI3K/AKT pathway
hyperactivation and thyroid cancer progression by targeting PTEN.
Oncogene. 37:3369–3383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang L, Shi SB, Zhu Y, Qian TT and Wang
HL: Long non-coding RNA ASAP1-IT1 promotes cell proliferation,
invasion and metastasis through the PTEN/AKT signaling axis in
non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 22:142–149.
2018.PubMed/NCBI
|
|
25
|
Li T, Xiao Y and Huang T: HIF-1α-induced
upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by
inactivating the PTEN/AKT signaling pathway. Oncol Rep.
39:1072–1080. 2018.PubMed/NCBI
|
|
26
|
Pan C, Yao G, Liu B, Ma T, Xia Y, Wei K,
Wang J, Xu J, Chen L and Chen Y: Long noncoding RNA FAL1 promotes
cell proliferation, invasion and epithelial-mesenchymal transition
through the PTEN/AKT signaling axis in non-small cell lung cancer.
Cell Physiol Biochem. 43:339–352. 2017. View Article : Google Scholar : PubMed/NCBI
|
